EM Vivas · Acute agitation and rapid tranquillisation
The agitated stimulant patient — escalation viva
A clinical viva on the recognition and management of excited delirium complicating methamphetamine use — chemical control, active cooling, treatment of hyperkalaemia and acidosis, the avoidance of prone restraint, and the anticipation of rhabdomyolysis, arrhythmia and sudden death.
On this page
Study tools
Target exams
Interpretation
Reveal interpretationShowHide
This is excited delirium — agitation with hyperthermia, autonomic storm, pain indifference and continuous struggle — a time-critical medical emergency, not a containment problem. The combination of methamphetamine use, hyperthermia (39.6), tachycardia (152), hypertension, tachypnoea, diaphoresis and rigidity in a patient held prone by four officers for 12 minutes is the exact pattern the forensic literature on restraint-associated sudden death describes, and the patient is at imminent risk of positional asphyxia, hyperkalaemic arrhythmia, rhabdomyolysis, cardiovascular collapse and death.[1]
The immediate priority is to release prone restraint and reposition supine or lateral, while a sufficient clinical team (not police alone) takes over.[1] Airway, breathing, circulation are assessed in parallel. The bedside glucose is done (normal, excluding hypoglycaemia).[4] A resuscitation team is summoned. High-flow oxygen is applied. Intravenous access is secured as soon as the patient is chemically controlled.
Chemical control is the priority because physical containment is the mechanism of death.[1] First-line is a high-dose benzodiazepine plus droperidol intramuscularly — lorazepam 1 to 2 mg IM or midazolam 5 to 10 mg IM, with droperidol 5 to 10 mg IM. The Cole 2026 trial confirms droperidol as effective first-line for methamphetamine-associated agitation.[2] For refractory agitation, ketamine 4 mg per kg IM for dissociative control is used in the specialist or pre-hospital setting, with full airway equipment immediately available, recognising the risks of hypersalivation, emergence and laryngospasm. Active cooling is begun immediately: remove clothing, evaporative cooling with tepid water and fans, ice packs to the groins, axillae and neck; consider cold intravenous fluids. Hyperkalaemia and acidosis are anticipated and treated: a venous gas is drawn, and hyperkalaemia is treated with intravenous calcium chloride or gluconate, insulin with dextrose, and salbutamol; acidosis is corrected with ventilation and, where appropriate, sodium bicarbonate. Rhabdomyolysis is anticipated: intravenous fluid loading to maintain a urine output of 1 to 2 mL per kg per hour, and a creatine kinase level is sent.[1]
The complications to anticipate are torsades de pointes from droperidol-related QT prolongation (pre-sedation and post-sedation ECG, electrolyte correction), aspiration in the over-sedated patient (lateral positioning, airway adjunct), acute kidney injury from rhabdomyolysis (fluid, monitoring), disseminated intravascular coagulation, hepatic dysfunction, and sudden death — the catastrophic outcome that chemical control, cooling and electrolyte correction are designed to prevent. Intubation and mechanical ventilation with lung-protective settings is the escalation for the patient who cannot be controlled medically, who has a rising lactate or worsening acidosis, or whose airway cannot be safeguarded.[1]
References4ShowHide
- [1]Tyr A, Lindeman E, Tamsen F, et al. Incidents of sudden death during restraint of agitated individuals in Sweden between 1992 and 2024. Journal of Forensic Sciences, 2026.PMID 41292063
- [2]Cole JB, DeVries PA, O'Flaherty JL, et al. Intramuscular droperidol, olanzapine, midazolam, or lorazepam to treat methamphetamine intoxication in the emergency department. American Journal of Emergency Medicine, 2026.PMID 41740194
- [3]Baldaçara L, Sanches M, Cordeiro DC, et al. Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone Braz J Psychiatry, 2011.PMID 21537720
- [4]Stowell KR, Florence P, Harman HJ, Glick RL. Psychiatric evaluation of the agitated patient: consensus statement of the American Association for Emergency Psychiatry Project BETA Evaluation Workgroup. Western Journal of Emergency Medicine, 2012.PMID 22461916